Cargando…
Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: Data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen Therapy
Background: Chronic obstructive pulmonary disease (COPD) is associated with cardiovascular disease. We investigated whether sleeping at altitude increases nocturnal heart rate (HR) and other markers of cardiovascular risk or arrhythmias in lowlanders with COPD and whether this can be prevented by no...
Autores principales: | Bisang, Maya, Latshang, Tsogyal D., Aeschbacher, Sayaka S., Huber, Fabienne, Flueck, Deborah, Lichtblau, Mona, Ulrich, Stefanie, Hasler, Elisabeth D., Scheiwiller, Philipp M., Ulrich, Silvia, Bloch, Konrad E., Furian, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956979/ https://www.ncbi.nlm.nih.gov/pubmed/33732710 http://dx.doi.org/10.3389/fmed.2021.557369 |
Ejemplares similares
-
Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial
por: Tan, Lu, et al.
Publicado: (2020) -
Altitude Travel in Patients With Pulmonary Hypertension: Randomized Pilot-Trial Evaluating Nocturnal Oxygen Therapy
por: Lichtblau, Mona, et al.
Publicado: (2020) -
Effect of Nocturnal Oxygen on Blood Pressure Response to Altitude Exposure in COPD – Data from a Randomized Placebo-Controlled Cross-Over Trial
por: Meszaros, Martina, et al.
Publicado: (2021) -
Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trial
por: Gutweniger, Sophia, et al.
Publicado: (2021) -
Effect of Nocturnal Oxygen Therapy on Daytime Pulmonary Hemodynamics in Patients With Chronic Obstructive Pulmonary Disease Traveling to Altitude: A Randomized Controlled Trial
por: Lichtblau, Mona, et al.
Publicado: (2021)